Manufacturing news briefs — stories you might have missed

Viraleze shows efficacy in Covid-19 patients – Starpharma Starpharma’s Viraleze antiviral nasal spray has demonstrated antiviral efficacy in a placebo-controlled study in participants with Covid-19. Viraleze achieved a statistically significant reduction in SARS-CoV-2 viral load, in the cohort of participants aged 45 and over. Viral load in the nose was reduced by 80 percent less…

Manufacturing news briefs – stories you might have missed

Altech receives commitments for another $2.5 million in investment Altech Batteries announced on Monday that it has received binding commitments for shortfall shares, following a non-renounceable entitlement offer, raising an additional $2,538,000 before costs. Total proceeds worth $15,838,208 have now been raised, including $3,000,000 from the recent placement, as well as the allocation of $12,838,208…

Starpharma, UQ target new radiopharmaceuticals

A federal government science grant and industry funding has sparked the creation of a new research and industry hub targeting the development of new radiopharmaceuticals. Pharmaceutical developer Starpharma has partnered with the University of Queensland and the University of Sydney in establishing the ARC Research Hub for Advanced Manufacture of Targeted Radiopharmaceuticals (AMTAR Hub). Backed…